$Bloom Energy Corp(BE)$ It's been a rough year for high beta names. Everything is heavily oversold and trading well below where it should be. The pain should be wrapping up soon, and from November through next year I think we fly.

The KOSPI is only $30 away from clearing the 6,000 level. If it can break above 6,185 this week, the KOSPI will move up from the oversold zone to the consolidation zone. $Direxion Daily MSCI South Korea Bull 3x Shares(KORU)$  $SK hynix(SKHY)$  $Roundhill Memory ETF(DRAM)$  $Direxion Daily Semiconductors Bull 3x Shares(SOXL)$  $Micron Technology(MU)$ 

Bloomberg had a solid segment on the space economy market size, touching on a few players in that area like VC-funded Icon Build out of Austin, along with some sovereign actors and Chinese companies. Science was never my strongest subject, so I leaned into data analysis and doubled down on math and finance instead. I may not understand regolith, but I do get that out of a $3.8T potential market size, $SpaceX(SPCX)$  has the same early mover advantage $Tesla Motors(TSLA)$  had, confirmed by AI by at least 6 years. Short version: I added more under $150. A month ago a trader placed a multi-million trade on 2029 $300 strike calls. Also, an artist contracted payload space for a palm-sized model hous

$ERock, Inc.(EROC)$ Anthropic is expected to IPO under ANTHZZX.P in November, and it looks like Eroc will be the one supplying power to their Texas AI data centers. I'm pretty bullish on that setup. $Bloom Energy Corp(BE)$  $Generac(GNRC)$  $GE Vernova Inc.(GEV)$ 

$Moderna, Inc.(MRNA)$ Merck's market cap is currently 358 Billion. Moderna's market cap is currently 80 Billion. Once Keytruda + Intismeran is approved for melanoma, the rest of the cancer treatment approvals will not be far behind. Priced in? Maybe for the short term, but once revenue starts flowing - not even close. In full-year 2025, Keytruda generated $31.7 Billion in worldwide sales, up 7% year-on-year, and accounted for more than half of Merck's pharmaceutical revenue. Keytruda was about half of Merck's total sales for 2025. Keytruda is used for 20 types of cancer, including melanoma. Since the combination of Keytruda and Intismeran reduced death and recurrence for melanoma in a statistically significant and clinically meaningful way (4

$SK hynix(SKHY)$  Is this real? The company is valued at 5X its past year revenue, and the stock price is 5X its past year earnings. And both are growing. If you were buying the grocery store or gas station in your neighborhood as a business, you would have to pay a higher cap rate for it. This is an advanced tech company, not a neighborhood gas station.

$Moderna, Inc.(MRNA)$ Still going strong. For those into bottom fishing and technicals, $Rivian Automotive, Inc.(RIVN)$  has a similar setup to what MRNA had when I was picking it up for dirt cheap at $24-25. The multi-year consolidation is the key part.

$Applied Optoelectronics(AAOI)$ Shorts had better cover before the 100% reversal.

Being short semiconductors in 2026 is financially irresponsible. It's earnings season, and bears will be crushed. $Direxion Daily Semiconductors Bear 3x Shares(SOXS)$  could be back in the 20s by mid next month. On top of that, we're entering the most bullish season for US equities.

$IREN Ltd(IREN)$ More than half of IREN's market cap is free cash. Their prepayment structure basically works like 0% interest loans to fund capex, and they own over 5 GW of grid to build and connect to in a premium energy market state. They still need to deliver on checkpoints, for sure. Their CEO stimulus packages are tied to shareholder value and have a 2-year runoff, meaning they need to maintain that shareholder value until 2033 to collect. But some people will keep going on about how it's trading on liquid this weekend.

$SpaceX(SPCX)$ It is wild that SPCX and TSLA now account for 6% of QQQ.

$SpaceX(SPCX)$  I have SpaceX fever, and the only cure for it is more SpaceX.

$SK hynix(SKHY)$ The current dip actually looks like a solid opportunity. Anyone who got out probably shouldn't be investing in this sector at all. This is just how semis behave, they're more volatile. You have to think like an investor, not a trader. Earnings are coming up fast and they should be strong.

$SK hynix(SKHY)$ Started an 82 share position, planning to flip it over the next few days.

$SpaceX(SPCX)$ Bears really think Apollo/Pimco financing $40B of NVIDIA compute for an investment-grade company is the bear case. SPCX isn't borrowing $40B to survive. It's borrowing to scale the infrastructure that could print future revenue. Wall Street is lining up capital for the buildout while bears are staring at the invoice. They saw the construction bill for the Death Star and decided the Empire was broke.

$Applied Optoelectronics(AAOI)$  Strong volume with over 12M shares traded, well above the 30-day average, and the price moved up 7%. That's the kind of action we need to see heading into earnings. I think we'll be over $150 by the ER. I'm buying the dips and holding.

$SpaceX(SPCX)$ All this Elon bashing seems to be having the opposite effect, the stock keeps climbing. It feels like there's room for a lot more upside. If the negativity really picks up, it might even push past $160.

$Direxion Daily MSCI South Korea Bull 3x Shares(KORU)$ It has been stuck in the 15.50 to 25.50 range for 2.5 months now. Honestly, not sure when it will break out of this zone. So for now, I'll reduce in the 25 to 25.50 area and buy back below 18. If it breaks and closes above 25.50, I'll consider adding more. Don't think it's happening, but if it falls under 16, then I'll add big. $SK hynix(SKHY)$  $Samsung Electronics Co., Ltd.(SSNLF)$  $iShares MSCI South Korea ETF(EWY)$  $Roundhill Memory ETF(DRAM)$ 

$SpaceX(SPCX)$  Just above the trend line on the 1 hour to open. Hit and pierced the top of the 1 hour Bollinger Band only to drop all the way down to pierce the bottom band on the 1 hour. Very strange market maker behavior. No law enforcement until possibly 2029. Criminals.

I'm long term bullish on $SpaceX(SPCX)$ , but right now it feels like it's just rangebound. The range used to be 143 to 155, and now it's 145.50 to 158.50. I'm just watching that range until the pattern shifts. I bought $Leverage Shares 2X Long SPCX Daily ETF(SPCH)$  and it's up just 7%. I'd like to ride it past 155, or add more if it pulls back. $Leverage Shares 2X Short SPCX Daily ETF(SSPC)$